• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以柠檬酸盐形式注射的铝-26和镓-67的人体代谢。

Human metabolism of aluminium-26 and gallium-67 injected as citrates.

作者信息

Priest N D, Newton D, Day J P, Talbot R J, Warner A J

机构信息

Biomedical Research Department, AEA Technology, Didcot, Oxon, UK.

出版信息

Hum Exp Toxicol. 1995 Mar;14(3):287-93. doi: 10.1177/096032719501400309.

DOI:10.1177/096032719501400309
PMID:7779460
Abstract
  1. 26Al and 67Ga were given as citrates to a healthy male volunteer by intravenous injection. The retention of both tracers was studied by body radioactivity measurement. Levels in blood and excreta were determined by gamma-ray spectrometry and/or accelerator mass spectrometry. 2. More than half of the 26Al had left the blood after 15 min and the decline continued, leaving < 1% in blood after 2 d; the losses occurred both to renal excretion and through uptake by other compartments. Estimated excretion up to 13 d was 83% (urine) and 1.8% (faeces). Whole-body retention of 15% at 13 d declined to approximately 4% at 1178 d, when the daily reduction corresponded to a biological half-life of 7 y, suggesting that sustained intake of dietary aluminium may lead to a progressively increasing internal deposit. 3. The metabolism of 67Ga differed markedly from that of 26Al in all aspects studied.
摘要
  1. 将26铝和67镓以柠檬酸盐的形式通过静脉注射给予一名健康男性志愿者。通过全身放射性测量研究了两种示踪剂的滞留情况。通过伽马射线能谱法和/或加速器质谱法测定血液和排泄物中的水平。2. 15分钟后,超过一半的26铝已离开血液,且下降仍在继续,2天后血液中残留量<1%;损失既有通过肾脏排泄的,也有被其他组织摄取的。估计13天内的排泄量为83%(尿液)和1.8%(粪便)。13天时全身滞留率为15%,到1178天时降至约4%,此时每日减少量相当于生物半衰期为7年,这表明持续摄入膳食铝可能导致体内沉积物逐渐增加。3. 在所有研究的方面,67镓的代谢与26铝明显不同。

相似文献

1
Human metabolism of aluminium-26 and gallium-67 injected as citrates.以柠檬酸盐形式注射的铝-26和镓-67的人体代谢。
Hum Exp Toxicol. 1995 Mar;14(3):287-93. doi: 10.1177/096032719501400309.
2
Inter-subject variability in the metabolism of aluminium following intravenous injection as citrate.静脉注射柠檬酸盐后铝代谢的个体间变异性。
Hum Exp Toxicol. 1995 Jul;14(7):595-9. doi: 10.1177/096032719501400707.
3
The bioavailability of 26Al-labelled aluminium citrate and aluminium hydroxide in volunteers.26铝标记的柠檬酸铝和氢氧化铝在志愿者体内的生物利用度。
Biometals. 1996 Jul;9(3):221-8. doi: 10.1007/BF00817919.
4
Uptake of 26-Al and 67-Ga into brain and other tissues of normal and hypotransferrinaemic mice.正常小鼠和转铁蛋白血症低下小鼠的大脑及其他组织对26-铝和67-镓的摄取。
Biometals. 1997 Jul;10(3):185-91. doi: 10.1023/a:1018399611243.
5
Uptake by man of aluminium in a public water supply.人体对公共供水系统中铝的摄取。
Hum Exp Toxicol. 1998 Jun;17(6):296-301. doi: 10.1177/096032719801700602.
6
Investigation of the aluminium biokinetics in humans: a 26Al tracer study.人体铝生物动力学研究:一项26Al示踪剂研究。
Food Chem Toxicol. 2004 Mar;42(3):363-71. doi: 10.1016/j.fct.2003.09.010.
7
Aluminium interaction with 67Ga uptake by human plasma and transferrin.
Clin Chim Acta. 1983 Aug 15;132(2):199-203. doi: 10.1016/0009-8981(83)90248-6.
8
Intestinal absorption of trace amounts of aluminium in rats studied with 26aluminium and accelerator mass spectrometry.用²⁶铝和加速器质谱法研究大鼠肠道对痕量铝的吸收。
Clin Sci (Lond). 1997 Apr;92(4):379-83. doi: 10.1042/cs0920379.
9
Effect of citrate on plasma aluminium concentration and aluminium excretion in the rat.柠檬酸盐对大鼠血浆铝浓度及铝排泄的影响。
Clin Sci (Lond). 1992 Oct;83(4):431-5. doi: 10.1042/cs0830431.
10
On the mechanisms of 67Ga and 59Fe uptake by tumors.
Nuklearmedizin. 1983 Jun;22(3):152-4.

引用本文的文献

1
Vaccines and the Eye: Current Understanding of the Molecular and Immunological Effects of Vaccination on the Eye.疫苗与眼睛:疫苗对眼睛的分子和免疫影响的现有认识。
Int J Mol Sci. 2024 Apr 26;25(9):4755. doi: 10.3390/ijms25094755.
2
Unexpected Serum and Urine Aluminum Concentrations in Pediatric Patients on Home Parenteral Nutrition.儿科患者家庭肠外营养的血清和尿液铝浓度意外升高。
Nutrients. 2023 Aug 17;15(16):3597. doi: 10.3390/nu15163597.
3
Urinary aluminium and its association with autism spectrum disorder in urban preschool children in Malaysia.
马来西亚城市学龄前儿童尿液中的铝及其与自闭症谱系障碍的关系。
PeerJ. 2023 May 12;11:e15132. doi: 10.7717/peerj.15132. eCollection 2023.
4
Nano alum: A new solution to the new challenge.纳米氧化铝:应对新挑战的新方案。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2060667. doi: 10.1080/21645515.2022.2060667. Epub 2022 Apr 26.
5
Physiology-based toxicokinetic modelling of aluminium in rat and man.基于生理学的大鼠和人体内铝的毒代动力学模型。
Arch Toxicol. 2021 Sep;95(9):2977-3000. doi: 10.1007/s00204-021-03107-y. Epub 2021 Aug 14.
6
Review: Vaccine Myth-Buster - Cleaning Up With Prejudices and Dangerous Misinformation.综述:疫苗迷思终结者——清除偏见和危险的错误信息。
Front Immunol. 2021 Jun 10;12:663280. doi: 10.3389/fimmu.2021.663280. eCollection 2021.
7
Evaluation of effective dose for a patient under Ga-67 nuclear examination using TLD, water phantom and a simplified model.应用 TLD、水模体和简化模型评估 Ga-67 核素检查患者的有效剂量。
J Radiat Res. 2012 Nov 1;53(6):989-98. doi: 10.1093/jrr/rrs050. Epub 2012 Aug 21.
8
A model of the kinetics of lanthanum in human bone, using data collected during the clinical development of the phosphate binder lanthanum carbonate.利用碳酸镧磷酸盐结合剂临床研发期间收集的数据建立的人体骨骼中镧动力学模型。
Clin Pharmacokinet. 2008;47(8):543-52. doi: 10.2165/00003088-200847080-00004.
9
Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.铝、氧化铝和氢氧化铝的人体健康风险评估。
J Toxicol Environ Health B Crit Rev. 2007;10 Suppl 1(Suppl 1):1-269. doi: 10.1080/10937400701597766.
10
The bioavailability of 26Al-labelled aluminium citrate and aluminium hydroxide in volunteers.26铝标记的柠檬酸铝和氢氧化铝在志愿者体内的生物利用度。
Biometals. 1996 Jul;9(3):221-8. doi: 10.1007/BF00817919.